Ensitrelvir in hospitalized patients with COVID-19 who were moderately to severely immunocompromised: a single-center cohort study
{{output}}
Background: Immunocompromised patients have a risk of severe COVID-19. Objectives: To describe the outcomes of ensitrelvir in hospitalized immu... ...
